AzTrials
AzTrials

HealthyGAITRITENCT01443052

Gait Parameters Analysis in Post-stroke Patients and in Elderly Fallers

An observational study of Healthy and Thalamic Pain Syndrome, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A large proportion of falls in older people occurs when walking. Most studies have recently demonstrated correlation between the variations in spatiotemporal gait parameters and fall risk in elderly and in several diseases. Read more about this study

Who is it for?
Ages 65 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Healthy, Thalamic Pain Syndrome, Fallers
What is being tested?
Gait analysis
How many people
62 participants
Where
1 siteFrance
Study dates
Nov 2010to Jul 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: subjects aged 65-80 years : 30 healthy people, 30 patients at least one year post-stroke, and 30 fallers

  1. For healthy subjects
  • Aged 65 to 80 years (included) ;
  • Patient has been informed and has signed the consent form.
  1. For post-stroke patients
  • Aged 65 to 80 years (included) ;
  • Stroke patients who had only one cerebrovascular accident, at least one year before inclusion ;
  • Able to walk without using assisting devices or ambulatory aids ;
  • No cardiovascular contraindication ;
  • No history of neurological diseases with influence on walking capacities (excepted stroke) ;
  • No history of vestibular or orthopaedic (lower limb) disorders ;
  • No amblyopia ;
  • Patient has been informed and has signed the consent form.
  1. For fallers
  • Aged 65 to 80 years (included) ;
  • Reported 2 or more falls within 6 months prior to the beginning of the study ;
  • Able to walk without using assisting devices or ambulatory aids ;
  • No cardiovascular contraindication ;
  • No history of neurological diseases with influence on walking capacities ;
  • No history of vestibular or orthopaedic (lower limb) disorders ;
  • No amblyopia ;
  • Patient has been informed and has signed the consent form.

Trial locations and contacts

1 site in 1 country.

France1 site
  • PRM Department - Lariboisiere Hospital

    Paris, 75010

Other trials in France

About this study

Official title: Study of the Temporospatial Gait Parameters With the Electronic Carpet "GAITRite" in Patients With Walking Impairment After Stroke and in Old Faller Subjects

A large proportion of falls in older people occurs when walking. Most studies have recently demonstrated correlation between the variations in spatiotemporal gait parameters and fall risk in elderly and in several diseases. The investigators objective is to analyse this parameters in population with gait stability disorders (post-stroke patients and fallers) to identify the most valuable and to develop/test a conglomerate stability score.

Read the detailed description

Temporal-spatial gait parameters will be recorded in subjects aged 65-80 years : 30 healthy people, 30 patients at least one year post-stroke, and 30 fallers while walking on an electronic walkway GAITRite® at self-selected speed.

Being tested
Gait analysis
Keywords
Gait stability, Spatiotemporal parameters, Walking, Elderly people, Stroke, Fallers
Medical subject headings
Thalamic Diseases, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gait analysisOther

    walking on an electronic walkway GAITRite® at self-selected speed

Study groups in NCT01443052
Study groupRoleWhat they receive
post-stroke patientsStroke patients who had only one cerebrovascular accident, at least one year before inclusion and Able to walk without using assisting devices or ambulatory aids
Receives: Other: Gait analysis
healthy subjectsAged 65 to 80 years
Receives: Other: Gait analysis
fallersReported 2 or more falls within 6 months prior to the beginning of the study and Able to walk without using assisting devices or ambulatory aids
Receives: Other: Gait analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. GAIT parameters

    Spatiotemporal gait parameters registered by a GAITRite walkway system, including mean and coefficient of variation for step and cycle length and time, base of support, speed, cadence, single and double support phase, stance and swing phase.

    Measured: at inclusion

Secondary outcomes (3)
  1. Functional Ambulation Performance Score

    a score which represents a quantification of patients' gait based on a selection of spatiotemporal parameters obtained at a self-selected speed.

    Measured: at inclusion

  2. Rivermead Motricity Index

    For post-stroke patients

    Measured: at inclusion

  3. Berg Balance Scale

    For post-stroke patients

    Measured: at inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2011 (estimated)
  2. Study startNov 2010
  3. Primary completionJul 2015
  4. Study completionJul 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01443052
Sponsor's protocol ID
UC1002
Acronym
GAITRITE
Status last verified
Jun 2021
First submitted
4 May 2011
Last updated
15 Jun 2021
Results posted
No
Data monitoring committee
No

Publications

  • Hausdorff JM, Rios DA, Edelberg HK. Gait variability and fall risk in community-living older adults: a 1-year prospective study. Arch Phys Med Rehabil. 2001 Aug;82(8):1050-6. doi: 10.1053/apmr.2001.24893.

    PubMed 11494184
  • Hausdorff JM, Nelson ME, Kaliton D, Layne JE, Bernstein MJ, Nuernberger A, Singh MA. Etiology and modification of gait instability in older adults: a randomized controlled trial of exercise. J Appl Physiol (1985). 2001 Jun;90(6):2117-29. doi: 10.1152/jappl.2001.90.6.2117.

    PubMed 11356774
  • Bilney B, Morris M, Webster K. Concurrent related validity of the GAITRite walkway system for quantification of the spatial and temporal parameters of gait. Gait Posture. 2003 Feb;17(1):68-74. doi: 10.1016/s0966-6362(02)00053-x.

    PubMed 12535728
  • Menz HB, Latt MD, Tiedemann A, Mun San Kwan M, Lord SR. Reliability of the GAITRite walkway system for the quantification of temporo-spatial parameters of gait in young and older people. Gait Posture. 2004 Aug;20(1):20-5. doi: 10.1016/S0966-6362(03)00068-7.

    PubMed 15196515
  • Balasubramanian CK, Neptune RR, Kautz SA. Variability in spatiotemporal step characteristics and its relationship to walking performance post-stroke. Gait Posture. 2009 Apr;29(3):408-14. doi: 10.1016/j.gaitpost.2008.10.061. Epub 2008 Dec 3.

    PubMed 19056272
  • Gouelle A, Megrot F, Presedo A, Pennecot GF, Yelnik A. Validity of Functional Ambulation Performance Score for the evaluation of spatiotemporal parameters of children's gait. J Mot Behav. 2011;43(2):95-100. doi: 10.1080/00222895.2010.538768.

    PubMed 21298587

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy and Thalamic Pain Syndrome, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

GAIT parameters (time frame: at inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01443052, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
GAITRITE Clinical Trial NCT01443052 | AzTrials